Brandon Swift
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 13, 2025
Analysis of C4 Concentrations to Predict Impact of Patient-Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat.Fernando Carreño, Rashmi Mehta, Andrea Ribeiro de Souza
|May 23, 2024
Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat.Eleni Karatza, Brandon Swift, Fernando Carreño
|Dec 23, 2023
Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor.Konstantinos Stamatopoulos, Nena Mistry, Nikoletta Fotaki
|Nov 13, 2023
Population Dose-Response-Time Analysis of Itch Reduction and Patient-Reported Tolerability Supports Phase III Dose Selection for Linerixibat.Fernando Carreño, Eleni Karatza, Rashmi Mehta
|Jan 16, 2023
Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters.Aline Barth, Caroline R Perry, Shaila Shabbir
|Jun 30, 2022
Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects.Courtney Tiffany, Etienne F Dumont, Mohammad Hossain
Pageof 1
